Tag: podcast

Since SARS-CoV-2 was discovered in Illinois over a year ago, Feinberg scientists have been tracking the evolution of the disease in the Chicago area. Ramón Lorenzo Redondo, PhD, research assistant professor of Medicine in the Division of Infectious Diseases, is part of the team leading this work. He talks about the team’s research, the new…

Mercedes Carnethon, PhD, a Northwestern Medicine epidemiologist and population science expert, talks about how COVID-19 is affecting Black, Indigenous, Latinx and other people of color the most and what can be done to help these vulnerable communities as the pandemic continues and vaccine rollout lags behind.

Breakthroughs host Erin Spain takes a look back on the year 2020 and how Feinberg scientists responded to COVID-19 while publishing high-impact papers unrelated to the pandemic and making vital discoveries across the research enterprise during a difficult time.

Ankit Bharat, MBBS, Chief of Thoracic Surgery at Northwestern Medicine and director of the Lung Transplant program, shares findings that support why lung transplantation should be considered for patients who have developed irreversible lung disease due to COVID-19.

A $30 million dollar, phase 3 clinical trial at Northwestern is set to investigate whether exercise can slow Parkinson’s disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences, is leading the trial and explains what he hopes to accomplish.

Colon cancer is one of the most common cancers in the United States, with more than 100,000 new cases diagnosed every year. Surgery is often the primary treatment. A new Northwestern Medicine study shows patients whose surgery was performed by a highly skilled surgeon had a 70 percent lower risk of dying over five years…

A rare blood disorder related to people missing a protein, called PAI-1, was identified in a small Amish community. Douglas Vaughan, MD, studies the community and found that those without the protein seem to live longer and healthier lives. Now a PAI-1 inhibitor drug will be used for the first time in the U.S. in…

As flu season begins and COVID-19 continues to spread, Michael Ison, MD, is here to share some of his latest findings. He is part of Northwestern research teams running studies both on COVID-19 and on influenza vaccines and treatments.

Millions of people are now living with COVID-19 and their long-term outcomes are unknown. Northwestern’s Jeffrey Linder, MD, says more research studies on this group are needed to provide better information about COVID-19 care before, during and beyond the hospital.

A team of Northwestern scientists have come together from across disciplines to develop a COVID-19 antibody test designed for at-home use. Elizabeth McNally, MD, PhD, is part of the team working on this test to determine prior exposure to the virus.